Skip to main content

Table 2 Drug-resistant gonorrhoea surveillance in 19 non-EU/EEA member states in the WHO European Region

From: Sexually transmitted infections in the non-European Union and European Economic Area of the World Health Organization European Region 2021–2023

Country

National Surveillance

Reporting to WHO-GASP

Challenges mentioned to participating in WHO-GASP

Albania

No

No

N/A

Andorra

No

No

N/A

Armenia

No

No

Lack of national AMR surveillance programs, Resource limitations, Technical expertise and capacity gaps, Limited coordination mechanisms

Azerbaijan

No

No

N/A

Belarus

No

Noa

N/A

Georgia

Yes

No

N/A

Israel

Yes

Noa

N/A

Kyrgyzstan

No

Noa

N/A

Monaco

No

No

N/A

Montenegro

No

No

No referent laboratory, Low testing rates, Limited number of isolates

North Macedonia

Yes

No

No information on how to report to WHO GASP

Republic of Moldova

No

No

Lack of infrastructure

San Marino

No

Unknown

N/A

Serbia

No

No

No national program, No national reference laboratory

Switzerland

Yes

Yes

N/A

Tajikistan

No

Unknown

N/A

Türkiye

No

Unknown

N/A

Ukraine

No

Noa

Lack of a single electronic data collection system, Insufficient provision of laboratory reagents, Lack of requirements

Uzbekistan

No

Unknown

N/A

  1. N/A not available
  2. aThese countries have reported to WHO GASP at least once by 2020 according to GHO data: https://www.who.int/data/gho/data/themes/topics/indicator-groups/indicator-group-details/GHO/number-of-isolates-tested-(who-gasp-amr)